Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Université Laval
$105,000.00
Cellular Study of the Pulmonary Innate Immune Response to Respiratory Viruses
FY 2009-10
Summary
Influenza A virus (IAV) is an important pathogen known to cause severe respiratory tract infections in the vulnerable population such as in children and in the elderly. Rapid activation of the immune response in the lungs is a key event that may contribute to diminish the severity of infection. During the last decade, many studies have highlighted the importance of pathogen recognition receptors quickly activated during early stages of infection. Upon activation, these receptors initiate the production of inflammatory mediators and antiviral molecules. Our project aims at specifically activating some of the mentioned receptors in order to treat IAV infections. Using the mouse model, we will evaluate the effect of the treatment on the control of IAV and on the restoration of proper lung function following infection. In a context where vaccines as well as certain drugs currently used in the clinic to prevent and control this virus have a variable efficacy, this study may provide alternative strategies to fight against influenza.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206101
Name
Coulombe François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Cellular Study of the Pulmonary Innate Immune Response to Respiratory Viruses
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Influenza Virus; Innate Immunity; Mouse Model; Virology
Abstract
Influenza A virus (IAV) is an important pathogen known to cause severe respiratory tract infections in the vulnerable population such as in children and in the elderly. Rapid activation of the immune response in the lungs is a key event that may contribute to diminish the severity of infection. During the last decade, many studies have highlighted the importance of pathogen recognition receptors quickly activated during early stages of infection. Upon activation, these receptors initiate the production of inflammatory mediators and antiviral molecules. Our project aims at specifically activating some of the mentioned receptors in order to treat IAV infections. Using the mouse model, we will evaluate the effect of the treatment on the control of IAV and on the restoration of proper lung function following infection. In a context where vaccines as well as certain drugs currently used in the clinic to prevent and control this virus have a variable efficacy, this study may provide alternative strategies to fight against influenza.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Coulombe, François
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~